What Happened?
Columbus, OH-based Sollis-Therapeutics Appointed Gregory Fiore as President and Chief Executive Officer
Date of management change: March 15, 2017
Columbus, OH-based Sollis-Therapeutics Appointed Gregory Fiore as President and Chief Executive Officer
Sollis Therapeutics is a privately held pharmaceutical company developing non-opioid analgesic products. Our first product is a long acting formulation of a compound with both analgesic and anti-inflammatory properties this combination is perfectly tailored to the treatment of severe neuropathic pain conditions such as sciatica.
Gregory Fiore is President and Chief Executive Officer at Sollis Therapeutics. Previously, Gregory held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: